The focus of this report is the four LSDs that can be screened for by all three of the multiplex methods, specifically Fabry disease, Gaucher disease (due to deficiency of acid beta-glucosidase, GBA), MPS I, and Pompe disease. This evidence concerns the gene GBA1 and Fabry disease.